rs35374168

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_173630.4(RTTN):​c.5143A>G​(p.Asn1715Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00415 in 1,613,620 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 29 hom. )

Consequence

RTTN
NM_173630.4 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.99

Publications

6 publications found
Variant links:
Genes affected
RTTN (HGNC:18654): (rotatin) This gene encodes a large protein whose specific function is unknown. Absence of the orthologous protein in mouse results in embryonic lethality with deficient axial rotation, abnormal differentiation of the neural tube, and randomized looping of the heart tube during development. In human, mutations in this gene are associated with polymicrogyria with seizures. In human fibroblasts this protein localizes at the ciliary basal bodies. Given the intracellular localization of this protein and the phenotypic effects of mutations, this gene is suspected of playing a role in the maintenance of normal ciliary structure which in turn effects the developmental process of left-right organ specification, axial rotation, and perhaps notochord development. [provided by RefSeq, Jan 2013]
RTTN Gene-Disease associations (from GenCC):
  • microcephalic primordial dwarfism due to RTTN deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • bilateral generalized polymicrogyria
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062135756).
BP6
Variant 18-70054173-T-C is Benign according to our data. Variant chr18-70054173-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00254 (387/152308) while in subpopulation NFE AF = 0.00475 (323/68024). AF 95% confidence interval is 0.00432. There are 2 homozygotes in GnomAd4. There are 174 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTTNNM_173630.4 linkc.5143A>G p.Asn1715Asp missense_variant Exon 38 of 49 ENST00000640769.2 NP_775901.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTTNENST00000640769.2 linkc.5143A>G p.Asn1715Asp missense_variant Exon 38 of 49 2 NM_173630.4 ENSP00000491507.1

Frequencies

GnomAD3 genomes
AF:
0.00255
AC:
388
AN:
152190
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00476
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00216
AC:
539
AN:
249348
AF XY:
0.00214
show subpopulations
Gnomad AFR exome
AF:
0.000840
Gnomad AMR exome
AF:
0.000841
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000417
Gnomad NFE exome
AF:
0.00415
Gnomad OTH exome
AF:
0.00297
GnomAD4 exome
AF:
0.00432
AC:
6317
AN:
1461312
Hom.:
29
Cov.:
30
AF XY:
0.00420
AC XY:
3056
AN XY:
726968
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33472
American (AMR)
AF:
0.00105
AC:
47
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86238
European-Finnish (FIN)
AF:
0.000562
AC:
30
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00545
AC:
6059
AN:
1111538
Other (OTH)
AF:
0.00248
AC:
150
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
280
560
839
1119
1399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00254
AC:
387
AN:
152308
Hom.:
2
Cov.:
33
AF XY:
0.00234
AC XY:
174
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41572
American (AMR)
AF:
0.00105
AC:
16
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00475
AC:
323
AN:
68024
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00344
Hom.:
22
Bravo
AF:
0.00240
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00134
AC:
5
ESP6500EA
AF:
0.00256
AC:
21
ExAC
AF:
0.00195
AC:
236
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00349
EpiControl
AF:
0.00403

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jun 26, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RTTN: BS2 -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28518170) -

not specified Benign:2
Mar 12, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 27, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 06, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RTTN-related disorder Benign:1
Feb 13, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.19
T;.
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.084
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.73
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0062
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.6
M;M
PhyloP100
5.0
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.1
.;N
REVEL
Benign
0.18
Sift
Benign
0.54
.;T
Sift4G
Benign
0.44
.;T
Polyphen
0.55
P;.
Vest4
0.49
MVP
0.43
MPC
0.12
ClinPred
0.029
T
GERP RS
4.2
Varity_R
0.10
gMVP
0.43
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35374168; hg19: chr18-67721409; API